SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
"My old millionaire boss picked a penny up off the workshop floor, handed it to me, and said, 'There's your wages,' then ...
Takeda Canada Inc. (“Takeda”) is pleased to announce that Ontario Drug Benefit (ODB) include FruzaqlaTM (fruquintinib capsules) in the list of drugs eligible for ...